Nine Vanderbilt technologies were awarded U.S. patent protection in April. The technologies range from new therapeutic compounds to a heat transfer fluid.
Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators |
|
Polar nematic compounds |
|
Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors |
|
Materials comprising deaggregated diamond nanoparticles |
|
Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M.sub.1 receptors |
|
Alkyl 3-((2-amidoethyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate analogs as selective M1 agonists and methods of making and using same |
|
Cleavable surfactants and methods of use thereof |
|
Polar nematic compounds |
|
Methods and compositions for vein harvest and autografting |